When you're in the hospital with a serious infection, you want the treatment that works best. Doctors sometimes consider using higher doses of a powerful antibiotic called ceftriaxone, hoping it might clear the infection faster or more completely. But a new analysis of eight previous studies, involving over 5,000 adult patients, found no clear benefit to using more than the standard 1-gram daily dose for infections outside the brain and spinal cord.
The research, which pooled data from thousands of patient records, showed no statistically significant difference in whether patients were cured, how long they stayed in the hospital, or whether they survived. The numbers for cure and survival were virtually identical between the higher-dose and standard-dose groups. It's important to note this analysis looked at a mix of different study types and found considerable variation in the hospital stay results, meaning the answer isn't perfectly clear-cut.
This review has some important limitations. It couldn't account for the specific type of infection each patient had or factors that change how the body processes the drug, like low protein levels in the blood. Because of this, the findings may not apply to very high-risk infections or to patients whose bodies handle medication differently. The analysis also did not report on side effects or safety, so we don't know if higher doses carried more risks.
For now, this large review suggests that for many adults with common serious infections, the standard 1-gram dose of ceftriaxone might be just as effective as giving more. It's a reminder that more medicine isn't always better medicine, though doctors will still make dose decisions based on each patient's unique situation.
